Anti-Interferon-α-Therapy of systemic Lupus erythematosus

被引：0
|
作者：
Specker, C. [1 ]
机构：
[1] Kliniken Essen Sud, Zentrum Innere Med, Abt Rheumatol & Klin Immunol, D-45239 Essen, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷 / 08期
关键词：
PHASE-I; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; SAFETY;
D O I：
10.1007/s00393-013-1265-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：827 / 829
页数：3
相关论文
共 50 条
  • [21] Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?
    Massarotti, Elena M.
    Allore, Heather G.
    Costenbader, Karen
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) : 245 - 248
  • [22] Targeting interferon-α:: a promising approach for systemic lupus erythematosus therapy
    Schmidt, K
    Ouyang, W
    LUPUS, 2004, 13 (05) : 348 - 352
  • [23] Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus
    Werth, Victoria P.
    Fiorentino, David
    Sullivan, Barbara A.
    Boedigheimer, Michael J.
    Chiu, Kit
    Wang, Christine
    Arnold, Gregory E.
    Damore, Michael A.
    Bigler, Jeannette
    Welcher, Andrew A.
    Russell, Chris B.
    Martin, David A.
    Chung, James B.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (05) : 1028 - 1034
  • [24] RESULTS OF A RANDOMIZED PLACEBO CONTROLLED PHASE IA STUDY OF AGS-009, A HUMANIZED ANTI-INTERFERON-α MONOCLONAL ANTIBODY IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tcherepanova, I.
    Curtis, M.
    Sale, M.
    Miesowicz, F.
    Nicolette, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 536 - 537
  • [25] Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Matsumura, Ryutaro
    Saito, Kazuyoshi
    Yoshimura, Mitsuhiro
    Amano, Koichi
    Atsumi, Tatsuya
    Suematsu, Eiichi
    Hayashi, Nobuya
    Wang, Liangwei
    Tummala, Raj
    MODERN RHEUMATOLOGY, 2020, 30 (01) : 93 - 100
  • [26] Systemic Lupus Erythematosus Pathogenesis: Interferon and Beyond
    Caielli, Simone
    Wan, Zurong
    Pascual, Virginia
    ANNUAL REVIEW OF IMMUNOLOGY, 2023, 41 : 533 - 560
  • [27] Interferon-γ polymorphisms in systemic lupus erythematosus
    JY Lee
    D Goldman
    LM Piliero
    M Petri
    KE Sullivan
    Genes & Immunity, 2001, 2 : 254 - 257
  • [28] SERUM INTERFERON IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SHOUNEE, S
    FANG, FS
    WEN, YM
    FANG, HL
    XING, HY
    BRITISH JOURNAL OF DERMATOLOGY, 1987, 117 (02) : 155 - 159
  • [29] Type I interferon in systemic lupus erythematosus
    Crow, M. K.
    INTERFERON: THE 50TH ANNIVERSARY, 2007, 316 : 359 - 386
  • [30] The contribution of interferon lambda to systemic lupus erythematosus
    Macri, C.
    Pang, E. S.
    Pooley, J.
    Fancke, B.
    O'Keeffe, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1076 - 1076
12345